Veeva medtech clinical trials report signals significant opportunity to improve data delivery and quality

83% use email, portals, and paper to exchange information with study partners, slowing study execution and increasing risk of non-compliance pleasanton, calif. , april 19, 2023 /prnewswire/ -- veeva systems (nyse: veev) today released its first-ever report examining global trends in medtech clinical trials.
VEEV Ratings Summary
VEEV Quant Ranking